CYCC - Cyclacel Pharmaceuticals EPS in-line August, 13 2019 04:14 PM Cyclacel Pharmaceuticals Inc. Cyclacel Pharmaceuticals (NASDAQ:CYCC): Q2 GAAP EPS of -$0.16 in-line.Cash and cash equivalents of $17.5MPress ReleaseMore news on: Cyclacel Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, ,